U.S., Nov. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07246291) titled 'Comparative Study of EnliTuo(R) Before and After Technology Change in Healthy Male Volunteers' on Nov. 17.
Brief Summary: This study is a randomized, double-Blind, parallel-controlled, single-dose pharmacokinetic, safety, and immunogenicity comparative study of EnliTuo(R) before and after technology change in healthy male volunteers.
Study Start Date: Nov. 11
Study Type: INTERVENTIONAL
Condition:
Healthy Adult Male
Intervention:
BIOLOGICAL: New technology Enlituo
250 mg/m^2, single intravenous drip
BIOLOGICAL: Approved technology Enlituo
250 mg/m^2, single intravenous drip
Recruitment Status: RECRUITING
Sponsor: Taizhou M...